Andrea Spinelli

Andrea Spinelli serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions, from requirements definition and market research through solicitation, evaluation, award, and contract administration. Within the agency’s procurement framework, Spinelli ensures compliance with the Federal Acquisition Regulation (FAR) while advancing mission-critical objectives through strategic sourcing. Their portfolio primarily encompasses complex procurements in pharmaceutical manufacturing, diagnostic sciences, and professional scientific services, often involving technical specifications, regulatory adherence, and specialized vendor qualifications. Spinelli’s work supports the acquisition of high-integrity products and services essential to public health and scientific advancement. While specific contractor names are not available, Spinelli maintains a consistent engagement pattern with vendors possessing expertise in life sciences manufacturing and research services. Their contracting approach emphasizes competitive solicitation under full and open competition, with a preference for firms capable of meeting stringent quality, compliance, and scalability standards. Vendor partnerships are typically formed with entities demonstrating proven capabilities in GMP environments, laboratory validation, and scientific R&D, fostering long-term reliability and performance accountability. Spinelli’s procurement strategy reflects a strong orientation toward full and open competition, with 85.7% of awards issued without set-asides. However, a meaningful 14.3% of contracts are awarded under Total Small Business Set-Asides (FAR 19.5), demonstrating a deliberate commitment to expanding opportunities for small businesses in technical and scientific sectors. This balance underscores a compliance-driven approach that prioritizes market competitiveness while intentionally enabling small business participation where feasible and justified by acquisition requirements. The primary NAICS focus areas include Pharmaceutical Preparation Manufacturing (325412), In-Vitro Diagnostic Substance Manufacturing (325413), and Research and Development in the Physical, Engineering, and Life Sciences (541712), alongside Office Administrative Services (561110) and Other Professional, Scientific, and Technical Services (541990). Spinelli routinely procures sterile drug formulations, diagnostic reagents, laboratory testing services, and scientific consulting solutions, requiring deep familiarity with FDA regulatory frameworks, clinical validation protocols, and technical service delivery standards.